CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-021-02859-x
Abstract: Regulatory T cells (Tregs) are often enriched in tumors, where their immunosuppressive function has a key role in tumor persistence and progression. In colorectal cancer (CRC), however, Tregs are frequently associated with an improved clinical… read more here.
Keywords: ox40 treg; cd30 ox40; cd30; colorectal cancer ... See more keywords
Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis
Sign Up to like & getrecommendations! Published in 2018 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-018-5018-3
Abstract: BackgroundDiagnosis of pediatric inflammatory bowel diseases (IBD) remains challenging. We aimed at the value of immunohistochemical assessment of CD30+ lymphocytes in the intestinal mucosa in differential diagnosis between pediatric Crohn’s disease (CD) and ulcerative colitis… read more here.
Keywords: assessment cd30; cd30; diagnosis; colon ... See more keywords
Difficultés du diagnostic du lymphome T cutané anaplasique à grandes cellules CD30 positives
Sign Up to like & getrecommendations! Published in 2019 at "Annales De Dermatologie Et De Venereologie"
DOI: 10.1016/j.annder.2019.09.417
Abstract: Introduction Le lymphome T cutane anaplasique a grandes cellules est un lymphome T cutane (LTC) de bon pronostic avec expression de CD30 par plus de 75 % des cellules. Les lymphomes T cutanes primitifs qui ne correspondent… read more here.
Keywords: cd30; anaplasique; anaplasique grandes; expression cd30 ... See more keywords
A Phase Ib/II Study of Anti-CD30 Chimeric Antigen Receptor T Cells for Relapsed/Refractory CD30+ Lymphomas
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.149
Abstract: Introduction Treatment with chimeric antigen receptor modified T cells targeting CD30 (CD30.CAR-Ts) without lymphodepletion was found to be safe with preliminary efficacy in patients (pts) with relapsed/refractory (r/r) CD30+ lymphomas (Ramos et al., JCI 2017).… read more here.
Keywords: benda; flu; lymphodepletion; cd30 ... See more keywords
A Review of Primary Cutaneous CD30+ Lymphoproliferative Disorders.
Sign Up to like & getrecommendations! Published in 2019 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2018.08.003
Abstract: Primary cutaneous CD30+ lymphoproliferative diseases (LPDs) comprise a range of diseases (LyP, pcALCL, and borderline lesions) with broad histologic and phenotypical characteristics, although they all share the common feature of a favorable prognosis notwithstanding histology… read more here.
Keywords: cutaneous cd30; cd30; review primary; primary cutaneous ... See more keywords
Diagnostic, prognostic and therapeutic role of CD30 in lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2017.1270202
Abstract: ABSTRACT Introduction: CD30 is a cell surface receptor expressed in classical Hodgkin lymphoma (HL), anaplastic large cell lymphoma (ALCL), and many other lymphomas to a variable degree. It has been identified as an important therapeutic… read more here.
Keywords: lymphoma; role cd30; cd30; diagnostic prognostic ... See more keywords
Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Sign Up to like & getrecommendations! Published in 2019 at "Aesthetic surgery journal"
DOI: 10.1093/asj/sjy327
Abstract: BACKGROUND Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon type of non-Hodgkin lymphoma occurring in the fluid or capsule adjacent to textured breast implants. Diagnosis of BIA-ALCL of symptomatic patients requires demonstration of… read more here.
Keywords: lymphoma; breast implant; cd30; bia alcl ... See more keywords
Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30+ Lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx091
Abstract: Abstract Brentuximab vedotin is an antibody-conjugated chemotherapy targeting CD30 indicated in treatment of several lymphomas. We report the first 3 cases of cytomegalovirus severe infections with retinitis following this treatment. Evolution was favorable, but relapse… read more here.
Keywords: brentuximab vedotin; treatment; cd30; cytomegalovirus infection ... See more keywords
Prevalence of CD30 immunostaining in neoplastic mast cells
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010642
Abstract: Abstract Mastocytosis is a rare disease characterized by clonal neoplastic proliferation of mast cells (MCs). It ranges from skin lesions as cutaneous mastocytosis (CM) which may spontaneously regress to highly aggressive neoplasms with multiorgan involvement… read more here.
Keywords: cd30; cd30 expression; mast cells; mast ... See more keywords
Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Dermatology"
DOI: 10.1111/bjd.19823
Abstract: CD30, also known as tumor necrosis factor receptor 8 (TNF-R 8), was primarily called Ki-1 and is a cell surface molecule which has first been described from a group of pathologists from Kiel in 1982.1… read more here.
Keywords: lymphoma; subtypes cutaneous; cd30; cutaneous lymphoma ... See more keywords
Impressive response of CD30‐negative, treatment‐refractory mycosis fungoides to brentuximab vedotin
Sign Up to like & getrecommendations! Published in 2019 at "Dermatologic Therapy"
DOI: 10.1111/dth.12835
Abstract: Brentuximab vedotin is a CD30‐antibody/drug conjugate which has demonstrated excellent response in treating CD30‐positive mycosis fungoides (MF) and anaplastic large cell lymphoma (ALCL). In this report, we present a patient with CD30‐negative MF refractory to… read more here.
Keywords: cd30; response; mycosis fungoides; cd30 negative ... See more keywords